Comparative Analysis of Niosomal Mefloquine and Cisplatin on Apoptosis and Angiogenesis in Breast Cancer: Insights from In Vitro and In Silico Studies - Top-Institutions - MDSpire

Comparative Analysis of Niosomal Mefloquine and Cisplatin on Apoptosis and Angiogenesis in Breast Cancer: Insights from In Vitro and In Silico Studies

  • By

  • Zohreh Salari

  • Ahmad Khosravi

  • Arezo Riahi

  • Elaheh Molaakbari

  • Ehsan Salarkia

  • Ali Reza Keyhani

  • Samira Sohbati

  • Ghazal Mansouri

  • Mina Khosravi

  • Mohammad Zarif

  • Mohammad Amin Raeisi Estabragh

  • November 26, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Breast Oncology
    • Cancer Pharmacology
    • Molecular Oncology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Breast Cancer Biology
    • Translational Oncology
    • Pharmacology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Breast Cancer Research
    • Cancer Pharmacology
    • Molecular Therapeutics

  • #4

    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

    Baltimore, MD

    Key Differentiators

    • Breast Cancer Therapeutics
    • Molecular Oncology
    • Drug Resistance

  • #5

    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center
    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center

    San Francisco, CA

    Key Differentiators

    • Breast Cancer Research
    • Nanomedicine
    • Cancer Pharmacology

Original Source(s)

Comparative Analysis of Niosomal Mefloquine and Cisplatin on Apoptosis and Angiogenesis in Breast Cancer: Insights from In Vitro and In Silico Studies

  • by Zohreh Salari, Ahmad Khosravi, Arezo Riahi, Elaheh Molaakbari, Ehsan Salarkia, Ali Reza Keyhani, Samira Sohbati, Ghazal Mansouri, Mina Khosravi, Mohammad Zarif, Mohammad Amin Raeisi Estabragh

  • November 26, 2025

Related Content

Diagnostic value of multimodal ultrasound imaging in triple-negative breast cancer

Vitamin D-related genetic variants as predictive biomarkers for breast cancer in Jordanian women

Prognostic Evaluation Using Nutrition-Inflammation Biomarkers from Routine Blood Tests in Metastatic Breast Cancer: A Boruta Algorithm-Optimized Feature Selection Study